The Columbus Dispatch

Justices to hear vaccine appeal

Ohio businesses await Supreme Court arguments on Biden mandate

- Mark Williams

Ohio businesses are gearing up to enforce President Joe Biden’s vaccine mandate even as the U.S. Supreme Court hears appeals this week that could block it from taking effect.

The legal fight is coming to a head as cases of coronaviru­s explode to record levels in Ohio and across the United States.

The court hears arguments on Thursday; the federal government has said it expects to begin enforcing the mandate on Jan. 10 unless the court acts.

“All eyes are on the Supreme Court for whatever might happen,” said Catherine Burgett, an employment law attorney with the Frost Brown Todd law firm in Columbus.

She has been advising clients to be prepared regardless of how the court decides. “Line up your ducks and recognize that you may have to eat them for dinner,” she said.

Almost immediatel­y after the administra­tion announced the rule, it was challenged in courts around the country by businesses and attorneys general, including Ohio Attorney General Dave Yost.

FDA vaccine chief Dr. Peter Marks said in a statement the agency made its decision because a booster “may help provide better protection against both the delta and omicron variants,” especially as omicron is “slightly more resistant” to the vaccine-induced antibodies that help fend off infection.

Real-world data from Israel tracked more than 6,300 12- to 15-year-olds who got a booster there at least five months after their second Pfizer dose and found no serious safety concerns, the FDA said.

Likewise, the FDA said even more data from Israel showed no problems with giving anyone eligible for a Pfizer booster that extra dose a month sooner than the six months that until now has been U.S. policy.

Vaccines still offer strong protection

against serious illness from any type of COVID-19. But health authoritie­s are urging everyone who’s eligible to get a booster dose for his or her best chance at avoiding milder breakthrou­gh infections from the highly contagious omicron mutant.

Children tend to suffer less serious illness from COVID-19 than adults. But child hospitaliz­ations are rising during the omicron wave – most of them unvaccinat­ed.

Pediatrici­an and global health expert Dr. Philip Landrigan of Boston College welcomed the FDA’S decisions, but stressed that the main need is to get the unvaccinat­ed their first shots.

“It is among unvaccinat­ed people that most of the severe illness and death from COVID will occur in coming weeks,” he said in an email. “Many thousands of lives could be saved if people could persuade themselves to get vaccinated.”

The vaccine made by Pfizer and its partner Biontech is the only U.S. option for children of any age. About 13.5 million 12- to 17-year-olds – just over half that age group – have received two Pfizer shots, according to the CDC.

For families hoping to keep their children as protected as possible, the booster age limit raised questions.

The older teens, 16- and 17-yearolds, became eligible for boosters in early December. But original vaccinatio­ns opened for the younger teens, those 12-15, back in May. That means those first in line in the spring, potentiall­y millions, are about as many months past their last dose as the slightly older teens.

As for even younger children, kidsize doses for 5- to 11-year-olds rolled out more recently, in November – and experts say healthy youngsters should be protected after their second dose for a while. But the FDA also said Monday that if children that young have severely weakened immune systems, they will be allowed a third dose 28 days after their second. That’s the same third-dose timing already recommende­d for immune-compromise­d teens and adults.

Pfizer is studying its vaccine, in even smaller doses, for children younger than 5.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education.

 ?? SHAFKAT ANOWAR/AP FILE ?? The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administra­tion allowing extra Pfizer shots for children as young as 12. Real-world data from Israel tracked more than 6,300 12- to 15-year-olds who got a booster after their second Pfizer dose and found no serious safety concerns.
SHAFKAT ANOWAR/AP FILE The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administra­tion allowing extra Pfizer shots for children as young as 12. Real-world data from Israel tracked more than 6,300 12- to 15-year-olds who got a booster after their second Pfizer dose and found no serious safety concerns.

Newspapers in English

Newspapers from United States